Literature DB >> 11576075

Working with male rodents may increase risk of allergy to laboratory animals.

A Renström1, A S Karlsson, P Malmberg, P H Larsson, M van Hage-Hamsten.   

Abstract

BACKGROUND: Our aim was to study the risk of laboratory animal allergy (LAA) among research staff working in laboratories separate from the animal confinement area. The roles of atopy and exposure intensity in LAA were studied with special regard to exposure to male rodents, who excrete higher levels of urinary allergens than female rodents.
METHODS: Eighty rodent-exposed subjects gave blood samples for the analysis of total IgE, Phadiatop, and specific IgE against rat (RUA) and mouse urinary allergens (MUA), and answered questionnaires. Air samples were collected for RUA and MUA aeroallergen measurement in both laboratories and animal confinement facilities.
RESULTS: Twenty percent of the subjects had IgE >0.35 kU/l to RUA and/or MUA, and 32% had experienced animal work-related symptoms, although 90% of aeroallergen samples from the research department laboratories were below the detection limit (<0.26 ng RUA per m(3) and <0.8 ng MUA per m(3)). Atopy (positive Phadiatop), total IgE >100 kU/l, other allergies (especially to other animals), or more than 4 years of exposure significantly increased laboratory animal sensitization and symptoms. Working with mainly male rodents gave odds ratios (95% CI) of 3.8 (0.97-15) for sensitization and 4.4 (1.4-14) for symptoms. Subjects with both exposure to mainly male rodents and atopy or elevated total IgE had a 10-fold higher frequency of sensitization than exposed subjects with neither risk factor.
CONCLUSION: A majority of subjects with a combination of exposure to mainly male rodents and atopy or elevated total IgE developed sensitization to and symptoms from laboratory animals. Current low exposure seems to maintain the presence of specific IgE. Further measures must be undertaken to provide a safe workplace for laboratory animal workers.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11576075     DOI: 10.1034/j.1398-9995.2001.00899.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  7 in total

1.  Rodent allergen in Los Angeles inner city homes of children with asthma.

Authors:  Jill Berg; Rob McConnell; Joel Milam; Judith Galvan; Jenny Kotlerman; Peter Thorne; Craig Jones; Ronald Ferdman; Peyton Eggleston; Cynthia Rand; Mary Ann Lewis; John Peters; Jean Richardson
Journal:  J Urban Health       Date:  2007-11-15       Impact factor: 3.671

Review 2.  A risk-based approach to reducing exposure of staff to laboratory animal allergens.

Authors:  Lynda Westall; Ian R Graham; James Bussell
Journal:  Lab Anim (NY)       Date:  2015-01       Impact factor: 12.625

Review 3.  Laboratory Animal Allergy in the Modern Era.

Authors:  Meinir Jones
Journal:  Curr Allergy Asthma Rep       Date:  2015-12       Impact factor: 4.806

Review 4.  Role of mouse allergens in allergic disease.

Authors:  Elizabeth C Matsui
Journal:  Curr Allergy Asthma Rep       Date:  2009-09       Impact factor: 4.806

5.  Risk factors associated with airway allergic diseases from exposure to laboratory animal allergens among veterinarians.

Authors:  Anna Krakowiak; Marta Wiszniewska; Patrycja Krawczyk; Bogdan Szulc; Tomasz Wittczak; Jolanta Walusiak; Cezary Pałczynski
Journal:  Int Arch Occup Environ Health       Date:  2006-10-05       Impact factor: 2.851

6.  Predictors for Increased and Reduced Rat and Mouse Allergen Exposure in Laboratory Animal Facilities.

Authors:  Anne Straumfors; Wijnand Eduard; Knut Andresen; Ann Kristin Sjaastad
Journal:  Ann Work Expo Health       Date:  2018-10-15       Impact factor: 2.179

7.  Distribution and determinants of mouse allergen exposure in low-income New York City apartments.

Authors:  Ginger L Chew; Matthew S Perzanowski; Rachel L Miller; Juan C Correa; Lori A Hoepner; Carlos M Jusino; Mark G Becker; Patrick L Kinney
Journal:  Environ Health Perspect       Date:  2003-08       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.